Fennec Pharmaceuticals (FENC) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Fennec Pharmaceuticals (FENC) over the last 15 years, with Q3 2025 value amounting to -$21.9 million.
- Fennec Pharmaceuticals' Enterprise Value rose 4556.8% to -$21.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$21.9 million, marking a year-over-year increase of 4556.8%. This contributed to the annual value of -$26.6 million for FY2024, which is 10072.35% down from last year.
- Fennec Pharmaceuticals' Enterprise Value amounted to -$21.9 million in Q3 2025, which was up 4556.8% from -$18.7 million recorded in Q2 2025.
- In the past 5 years, Fennec Pharmaceuticals' Enterprise Value registered a high of -$12.4 million during Q3 2023, and its lowest value of -$51.2 million during Q1 2024.
- For the 5-year period, Fennec Pharmaceuticals' Enterprise Value averaged around -$24.6 million, with its median value being -$23.2 million (2022).
- In the last 5 years, Fennec Pharmaceuticals' Enterprise Value surged by 5832.55% in 2023 and then tumbled by 28574.12% in 2024.
- Quarter analysis of 5 years shows Fennec Pharmaceuticals' Enterprise Value stood at -$24.3 million in 2021, then rose by 2.31% to -$23.8 million in 2022, then surged by 44.19% to -$13.3 million in 2023, then tumbled by 100.72% to -$26.6 million in 2024, then rose by 17.6% to -$21.9 million in 2025.
- Its last three reported values are -$21.9 million in Q3 2025, -$18.7 million for Q2 2025, and -$22.7 million during Q1 2025.